YouTube· GLOBAL IMMUNOTALKS · YouTube·· 13 hours agoPickScore71
Shizuo Akira Lecture: Endoribonuclease Regnase-1 Regulates Immunity and Metabolism
In brief
In a GLOBAL IMMUNOTALKS lecture, Shizuo Akira reported that the endoribonuclease Regnase-1 is a key regulator of immune and metabolic pathways, involving IκB degradation and NF-κB signaling.
Key points
Shizuo Akira reported that the endoribonuclease Regnase-1 acts as a key regulator of immune and metabolic pathways, linking NF-κB with multiple [pathways].
- Akira's team focused on Regnase-1 (an endoribonuclease) as a key regulator of immune and metabolic pathways; involving IκB degradation, initial phosphorylation sites, and NF-κB signaling.
- The content connects multiple inflammatory axes: cytokine signaling such as IL-17, IL-18, IL-33, and IL-36, along with related phosphorylation/ubiquitination regulation.
- Mentioned connections to the tumor microenvironment: experiments such as co-culture with B16-F10 melanoma cells and NK cell function (anti-NK markers, enhanced NK cell binding/metabolism).
- Note: The transcript is from automatic subtitles, and most terms are approximate speech-recognition renderings (e.g., H2, IκB, and the pronunciation of various IL numbers); the specific molecular names should be based on Akira's original paper/this conference's proceedings.
- Positioning: A frontier immunology mechanisms report.
Why it matters
The lecture links NF-κB signaling with multiple cytokine axes and NK cell experiments in the tumor microenvironment, providing mechanistic background on Regnase-1.
Source: YouTube